On the topic of Semler Scientific. Currently SMLR is partnered with two large payers in the US, accounting for 70% of total revenue in 2021 between the two. Do you see an opportunity for a significant jump in revenues if SMLR managed to partner with another large payer in the coming years? I would appreciate any perspective you could share regarding the likelihood and potential of such a scenario.
SMLR was disappointing but 2 bad quarters doesn't spell the end of the world. This next one will show February - May results—this will be crucial to see if the seasonality is front-loaded like management said
On the topic of Semler Scientific. Currently SMLR is partnered with two large payers in the US, accounting for 70% of total revenue in 2021 between the two. Do you see an opportunity for a significant jump in revenues if SMLR managed to partner with another large payer in the coming years? I would appreciate any perspective you could share regarding the likelihood and potential of such a scenario.
SMLR was disappointing but 2 bad quarters doesn't spell the end of the world. This next one will show February - May results—this will be crucial to see if the seasonality is front-loaded like management said